Project Grant R43FD004348

The National Science Foundation (NSF) awarded a $951,394 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Ballydel Technologies Inc. for the development of serialized anti-counterfeit labeling technology for pharmaceutical and biological products. The project aims to create a scalable manufacturing process for imprinting covert, encrypted patterns onto labels for individual vaccine vials, incorporating serialized codes to enable traceability...

This $150,000 Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) will fund Northeastern University's development of a network-enabled system to disrupt illicit trade in counterfeit and illegal medicines. Over a four-year period from August 2022 to July 2026, the university will employ criminological, computer science and pharmacological methods to identify intervention points and coordinate stakeholder efforts against illegal medical product flows....

Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an advanced medication adherence and monitoring system for decentralized clinical trials (DCTs) in substance use disorder (SUD) treatment. The award, effective from September 1, 2025, through August 31, 2026, supports the adaptation of Addinex's existing medication management platform to...

This $1,000,000 cooperative agreement from the National Science Foundation (NSF) will fund the development of a blockchain ecosystem and artificial intelligence to optimize prior authorization processes in the pharmaceutical industry. Red Oak Strategic LLC will leverage distributed ledger technology to create an encrypted, decentralized patient data sharing network among prescribers, payers, and patients. Smart contracts will automate criteria fulfillment, facilitate machine learning-based...

Refined Imaging, LLC was awarded a $200,000 cooperative agreement from the National Institute of Standards and Technology under the Science, Technology, Business and/or Education Outreach federal grant program to develop a secure, printable ink technique for cyber-tracking additive manufactured parts. The company will conduct proof of concept experiments to program 3D printers to modulate material porosity during deposition, resulting in an optically invisible patterned code that can be...

The National Institute of Standards and Technology (NIST) awarded Infratrac Inc., a woman-owned small business, a $400,000 Cooperative Agreement under CFDA 11.620 - Science, Technology, Business and/or Education Outreach. The purpose of the award is for Infratrac to build upon its prior Phase I research demonstrating an integrated system using non-destructive technology with the potential to enhance trust and safety for 3D printed drugs. Under the Phase II project, Infratrac will focus on...

The National Science Foundation (NSF) awarded a Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Resilient Lifescience, Inc. for the development and validation of a novel wearable medical device to detect and treat opioid overdose. The $274,964 award, effective March 15, 2024 through December 31, 2024, will fund the development of two key components: 1) a self-contained, patch-based drug delivery platform capable of reliably delivering multiple...

The National Science Foundation (NSF) Division of Information and Intelligent Systems awarded a $162,827 Project Grant to the University of Wisconsin - Madison, through the University of Wisconsin System, to develop an "Intelligent Pervasive Augmented Reality Therapy (IPAL)" system for managing opioid use disorder (OUD) and addiction. The 1-year project will integrate complementary psychotherapies like cognitive behavioral therapy and heart rate variability biofeedback with immersive...

This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...

This four-year project grant from the National Science Foundation's Division of Information and Intelligent Systems, under the Computer and Information Science and Engineering program (CFDA 47.070), provides $200,000 to the University of Houston to develop and evaluate a network-enabled system to disrupt illicit trade networks in counterfeit and illegal medicines. The multidisciplinary research team will identify intervention points and coordinate stakeholder efforts to disrupt illegal flows...